![Andre J. Gudger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andre J. Gudger
Director/Miembro de la Junta en
CytoDel LLC
.
Perfil
Andre J.
Gudger is currently the Director at CytoDel LLC.
Previously, he was the Chairman & Chief Executive Officer at Solvern Innovations, Inc. from 2003 to 2009.
He obtained an undergraduate degree from the University of Maryland and an MBA from The University of North Carolina at Charlotte.
Cargos activos de Andre J. Gudger
| Empresas | Cargo | Inicio |
|---|---|---|
CytoDel LLC
 CytoDel LLC BiotechnologyHealth Technology Operates as a biopharmaceutical company which produces recombinant derivatives of botulinum neurotoxin | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Andre J. Gudger.
| Empresas | Cargo | Fin |
|---|---|---|
Solvern Innovations, Inc.
 Solvern Innovations, Inc. Information Technology ServicesTechnology Services Provides information technology development and consultation services | Presidente | 01/01/2009 |
Formación de Andre J. Gudger.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
9
Relaciones de 1er grado
4
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
University of Maryland
 University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Solvern Innovations, Inc.
Solvern Innovations, Inc. Information Technology ServicesTechnology Services Provides information technology development and consultation services | Technology Services |
The University of North Carolina at Charlotte
 The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CytoDel LLC
CytoDel LLC BiotechnologyHealth Technology Operates as a biopharmaceutical company which produces recombinant derivatives of botulinum neurotoxin | Health Technology |
- Bolsa de valores
- Insiders
- Andre J. Gudger
